Posters
| SCH – Society of Comparative Hepatology | |
| SCH-P-1 Luckschander |
Differentiation of different types of feline liver disease by clinical features, cytology and laboratory test results |
| ESVC – European Society of Veterinary Cardiology | |
| ESVC-P-1 Carnabuci |
Left shift of the ventricular mean electrical axis in healthy Doberman Pinschers |
|
ESVC-P-2 |
Effects of a structured exercise program in sedentary dogs with asymptomatic myxomatous mitral valve disease: quality of life, and radiographic and echocardiographic parameters |
| ESVC-P-3 Parmentola |
Indeterminate mean electrical axis of the QRS complex in the dog |
| ESVC-P-4 O'Shaughnessy |
Clinical narrative analysis of clinical findings associated with measurement of N-terminal pro-B-type natriuretic peptide in dogs and cats |
| ESVC-P-5 Duarte |
Adverse Effects of amlodipine on the treatment of heart failure in dogs with myxomatous mitral valve disease: preliminary results |
| ESVC-P-6 Roels |
Assessment of pulmonary hypertension in dogs with angiostrongylosis before and after treatment |
| ESVC-P-7 Michalek |
Serum uric acid concentrations in dogs with chronic heart failure and atrial fibrillation |
| ESVC-P-8 Michalek |
Oxidative stress in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy |
| ESVC-P-9 Lo |
Is there an association between environmental factors and cardiovascular disease in dogs? |
| ESVC-P-10 Caivano |
Longitudinal right ventricle strain and strain rate by 2-dimensional speckle tracking echocardiography in dogs with pulmonary hypertension |
| ESVC-P-11 Poissonnier |
Epidemiological, clinical, echocardiographic features and prognosis of dogs with a thrilling murmur related to degenerative mitral valve disease: 374 cases (2006-2017) |
| ESVC-P-12 Heseltine |
A retrospective multi-centre study investigating evidence of thrombosis in dogs diagnosed with atrial fibrillation |
| ESVONC – European Society of Veterinary Oncology | |
| ESVONC-P-1 Johannes |
Expression of prostaglandin ep4 receptor in canine osteosarcoma |
| ESVONC-P-2 Cueni |
Methadone potentiates the effect of doxorubicin on a canine transitional carcinoma cell line |
| ESVONC-P-3 Ignatenko |
Clinical manifestations and response to the therapy of extragenital intranasal form canine transmissible venereal sarcoma(CTVT): retrospective study 11 dogs in Ukraine |
| ESVONC-P-4 Granziera |
The role of electrochemotherapy in management of tumours of the head in dogs |
| ESVONC-P-5 Cervone |
Feasibility, safety and diagnostic yield of ultrasound-guided fine needle aspiration of cardiac masses in dogs |
| ESVIM – European Society of Veterinary Internal Medicine | |
| ESVIM-P-1 Robin |
Meta-analysis of the association between Mycoplasma species and canine lower respiratory tract disease |
|
ESVIM-P-2 |
A questionnaire-based survey of owner-reported environment and care of West Highland white Terrier with or without idiopathic pulmonary fibrosis |
| ESVIM-P-3 Fastrès |
Investigation of serum Kebs von den lungen 6 (kl-6) concentration as a predisposing factor and in the diagnosis of canine idiopathic pulmonary fibrosis in the West Highland white Terrier |
| ESVIM-P-4 Nivy |
Trends in serum cobalamin, folate and total iron binding capacity concentrations in pregnant bitches and their association with hematological parameters and neonatal survival |
| ESVIM-P-5 Dominguez Ruiz |
Inter-clinician reliability of the respiratory physical examination in dogs and cats with abnormal breathing patterns |
| ESVIM-P-6 Galiazzo |
Endoscopic bronchial anatomy in the dog |
| ESVIM-P-7 Kehl |
A novel CMAH gene variant leading to blood type b in ragdolls |
| ESVIM-P-8 Pierini |
Evaluation of diet's effects and ability of the Hemoccult® assay for the detection of faecal occult blood in healthy dogs |
| ESVIM-P-9 Johnson |
Eosinophilic lung disease in 86 dogs (2006-2016) |
| ESVIM-P-10 Viitanen |
Systemic and local immunoglobulin concentrations in Irish wolfhounds with recurrent bacterial pneumonia |
| ESVIM-P-11 Crisi |
Evaluation of bronchoscopy and bronchoalveolar lavage findings in cats with Aelurostrongylus abstrusus in comparision to cats with feline bronchial disease |
| ESVIM-P-12 Palantzi |
Long term survival in two dogs with sterile multifocal osteomyelitis |
| ESVIM-P-13 Grotheer |
Retrospective comparison of cats with feline asthma and chronic bronchitis in a clinic population (2003 – 2016) |
| ESVIM-P-14 Grotheer |
Evaluation of long-term therapy in cats with feline asthma and chronic bronchitis |
| ESVIM-P-15 Määttä |
Matrix-metalloproteinase-7 activity in serum of West Highland White Terriers with idiopathic pulmonary fibrosis |
| ESVIM-P-16 Johnson |
Bronchoalveolar lavage lymphocytosis in dogs (2006-2016) |
| ESVIM-P-17 Bazelle |
Assessment of adverse effects of mycophenolate mofetil for treatment of immune mediated diseases in dogs |
| ESVIM-P-18 Blasi Brugué |
Prevalence of subclinical Haemotropic Mycoplasmosis in healthy indoor cats eligible to become blood donors in the Iberian Peninsula |
| ESVIM-P-19 Cocci |
Hyperplasia of the suprarytenoid pharyngeal fold in brachycephalic and nonbrachycephalic toy dogs: clinical presentation, treatment and outcome in 10 cases |
| ISCAID – International Society for Companion Animal Infectious Diseases | |
| ISCAID-P-1 Breu |
Diagnostics of canine Leishmania infection by ELISA and/or PCR-a comparative study |
| ISCAID-P-2 Su |
Clinical and laboratory findings of sixty naturally Babesia gibsoni infected dogs |
| ISCAID-P-3 Aboim |
Blood Cultures and the detection of multidrug-resistant bacteria in companion animals |
| ISCAID-P-4 Duque |
Use of neutrophil gelatinase–associated lipocalin (NGAL) in the early diagnosis of renal damage in canine leishmaniasis |
| ISCAID-P-5 Xenoulis |
Seroepidemiology of feline leukemia virus (felv) and feline immunodeficiency virus (fiv) in cats in Greece |
| ISCAID-P-6 Carreton |
Clinical Picture of Cats Seropositive for Dirofilaria immitis in a Hyperendemic Area: Is this Feline Disease Still Being Misdiagnosed? |
| ESVNU – European Society of Veterinary Nephrology and Urology | |
| ESVNU-P-1 van Israel |
Comparison of point-of-care (PocketchemTM UA) and reference laboratory protein/creatinine ratio measurements on canine and feline urine samples for diagnosis of proteinuria |
| ESVNU-P-2 Lauenstein-Bosse |
Evaluation of serum transforming growth factor beta 1 in cats with chronic kidney disease |
| ESVNU-P-3 Moberg |
Overweight and obesity did not predispose to subclinical bacteriuria in a mixed population of 152 middle aged and elderly cats – a prospective cross-sectional study |
| ESVNU-P-4 Sørensen |
In-house culture and susceptibility reduce antibiotic over-prescription in dogs with suspected cystitis – a randomized controlled trial |
| ESVNU-P-5 Oscarson |
Bacterial culture results from urine and ejaculates in healthy intact male dogs |
| ESVNU-P-6 Riesgo |
Retrospective study (2004-2017) of 137 uroliths diagnosed at the Complutense Veterinary Teaching Hospital |
| ESVNU-P-7 Dokuzeylül |
Clinical efficacy of the Marbofloxacin usage in dogs and cats diagnosed lower urinary tract disorders |
| ESVNU-P-8 Sargent |
Moderate dietary phosphate restriction and fibroblast growth factor 23 in healthy older cats |
| ESVNU-P-9 Monari |
Pattern of renal tubular damage and dysfunction in dogs with intrinsic acute kidney injury due to leptospirosis and other causes |
| ESVNU-P-10 Scarpa |
Big endothelin-1 in cats with CKD: preliminary evaluation |
| ESVNU-P-11 Carreton |
Evaluation of renal function in dogs infected by Dirofilaria immitis in relation to microfilaremia, parasite burden and pulmonary pressure |
| ESVNU-P-12 Defauw |
Evaluation of acute kidney injury in dogs with Babesia rossi infections |
| ESVNU-P-13 Burchell |
Salt and sugar in your larder make your kidneys work harder |
| ESCG – European Society of Comparative Gastroenterology | |
| ESCG-P-1 Cerquetella |
Proteomics of canine feces from healthy Boxer dogs: a pilot study |
| ESCG-P-2 Hayashi |
Elevated blood urea nitrogen and thrombocytopenia during treatment as prognostic factors for canine acute pancreatitis |
| ESCG-P-3 Ohta |
Expression of leucine rich alpha-2-glycoprotein (LRG) in the duodenal mucosa of dogs with chronic enteropathy |
| ESCG-P-4 Loze |
Differential diagnosis of ileocolic masses associated with intestinal obstruction in cats: A retrospective study of 8 cases (2015-2017) |
| ESCG-P-5 Marolf |
Comparison of computed tomographic angiography and ultrasonography in the diagnosis of acute canine pancreatitis |
| ESCG-P-6 Allenspach |
Canine jejunum and enteroids derived from healthy dogs are useful models to evaluate the gastrointestinal side effects of NSAIDs |
| ESCG-P-7 Marsilio |
Characterization of the fecal microbiome of cats with chronic enteropathy |
| ESCG-P-8 Lavoué |
Serine proteases activity in intestinal tissue of dogs with inflammatory bowel disease (IBD) - a new insight into the pathogenesis of IBD? |
| ESCG-P-9 Bertolani |
Hypercobalaminemia in 144 samples from cats and dogs |
| ESVE – European Society of Veterinary Endocrinology | |
| ESVE-P-1 Oliveira Leal |
The use of ACTH-depot for ACTH stimulation test in dogs with hyperadrenocorticism under trilostane therapy: changes to the conventional protocol |
| ESVE-P-2 Le Boedec |
Predictive model to estimate ionized calcium from routine serum biochemical profiles in cats |
| ESVE-P-3 Burchell |
Episodic nocturnal hypoglycaemia in healthy New Zealand working dogs |
| ESVE-P-4 Wehner |
Efficacy of orally administered anti-thyroid drugs for the treatment of hyperthyroid cats |
| ESVE-P-5 Lamoureux |
Iatrogenic hypoadrenocorticism following treatment with trilostane for hyperadrenocorticism in dogs: a description of 10 cases |
| ESVE-P-6 Stammeleer |
Evaluation of free T4 (fT4) measurement after equilibrium dialysis (FT4ED) and a chemiluminescent enzyme immunoassay (FT4CEIA) in hyperthyroid cats before and after treatment with radioiodine (131I ) |
| ESVE-P-7 García del Real Torralva |
Prevalence of hypokalemia in feline diabetes |
| ESVE-P-8 Pérez Alenza |
Evolution of trilostane dosage in dogs with pituitary dependent hyperadrenocorticism during the first year of treatment |
| ESVE-P-9 García San José |
Survival of dogs with naturally occurring hyperadrenocorticism |
| ESVE-P-10 Alonso Miguel |
Efficacy and safety of toceranib phospate in dogs diagnosed with beta cell neoplasia |
| ESVE-P-11 Burlacu |
Neural network based model for glycemic dynamics predictions in feline diabetes mellitus |
| ESVE-P-12 Carotenuto |
Use of tandem mass spectrometry (LC-MS/MS) for the measurement of thyroid hormones in dogs with spontaneous hypothyroidism |
| ESVE-P-13 Malerba |
Accuracy of a flash glucose monitoring system in dogs with diabetic ketoacidosis |
| ESVE-P-14 Rapastella |
Predictors of response to pituitary radiotherapy in dogs with and without pituitary dependent hyperadrenocorticism |
| ESVE-P-15 Gónzalez Sanz |
Telmisartan versus benazepril on the management of systemic hypertension in dogs with hyperadrenocorticism |
| ESVCP – European Society of Veterinary Clinical Pathology | |
| ESVCP-P-1 Nivy |
Efficacy of specific antivenin and fresh frozen plasma in reversing Daboia palaestinae venom-induced hemostatic derangement - an in vitro study |
| ESVCP-P-2 Gerke |
Insulin-like growth factor-1 and 26S proteasome as possible biomarker for metabolic states in dogs suffering from chronic diseases |
| ESVCP-P-3 Marazzi |
Preliminary investigation of haematological and biochemical parameters as prognostic markers in dogs with severe inflammation |
| ESVCP-P-4 Cantos Barreda |
Changes in anti-leishmania antibody levels in serum and saliva after three months of treatment in dogs with clinical leishmaniosis |
| ESVCP-P-5 Breu |
Prevalence of braf variant V450E in urine, smears, and biopsies of canine transitional cell carcinoma |
| ESVCP-P-6 Nielsen |
Global measurement of coagulation in plasma from healthy cats – a potential tool for detection of thrombosis |
| ESVCP-P-7 Miglio |
Breed Specific hemato - biochemical reference intervals for the adult hunting dogs using a blood donor data base |
| ESVCP-P-8 Rubio |
Effects of different storage conditions on markers of oxidative stress in canine serum samples |
| ESVCP-P-9 Franco Martinez |
The salivary proteome in dogs with canine parvovirosis |
| ESVCP-P-10 Gomez Fernandez - Blanco |
Beta-hydroxybutyrate and adiponectin in overweight healthy dogs |
| ESVCP-P-11 Franco-Martinez |
Validation of a new point-of-care immunoassay for serum cortisol measurement in canine serum samples |
| ESVCP-P-12 Vizi |
Evaluation of a point-of-care veterinary hematocrit meter in 57 dogs |
| ESVCP-P-13 Lidbury |
Analytical validation of a point-of-care assay for the measurement of serum C-reactive protein concentrations in dogs |
| ESVCN – European Society of Veterinary Comparative Nutrition | |
|
ESVCN-P-1 |
Studies on a new body condition scoring by morphometric methodin dogs (2nd report) |